Disclosures for "Donanemab in Early Alzheimer’s Disease: Greater Benefit in Lower Tau Burden"
-
Dr. Sajeendran has nothing to disclose.
-
Dr. Pitton Rissardo has nothing to disclose.
-
Dr. Elmandouh has nothing to disclose.
-
Dr. Fornari Caprara has nothing to disclose.